Galena Biopharma (RXII) Announces Clinical Development Collaboration With Genentech (RHHBY)/Roche (RHHBY) and The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) for NeuVax(TM) (E75) Combined With Herceptin(R) (trastuzumab) in Adjuvant Breast Cancer
11/28/2011 7:50:01 AM
More...
|
Dalton Pharma Services and The Henry M. Jackson Foundation Announce a Services Agreement for the Advancement of Military Medicine
10/5/2011 12:06:32 PM
More...
|
Pfenex Inc., Through its Reagent Proteins Business Division, Establishes Clinical Supply Agreement with Henry M. Jackson Foundation for the Advancement of Military Medicine
11/30/2010 11:06:15 AM
More...
|
Generex Biotechnology Corporation (GNBT) Establishes CRADA With The Uniformed Services University And The Henry M. Jackson Foundation For Novel Her-2/neu Vaccine Studies and Clinical Trials At Walter Reed Army Institute of Research In Patients With Breast Cancer
10/19/2005 5:09:13 PM
More...
|